Comparison of the Therapeutic Effects of [


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Aug 2022
Historique:
received: 29 07 2022
revised: 09 08 2022
accepted: 18 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

Astatine (

Identifiants

pubmed: 36012698
pii: ijms23169434
doi: 10.3390/ijms23169434
pmc: PMC9409053
pii:
doi:

Substances chimiques

Iodine Radioisotopes 0
Iodine-131 0
Astatine XI595HAL7H

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Science and Technology Agency
ID : JPMJOP1721

Références

Lancet Diabetes Endocrinol. 2014 May;2(5):356-8
pubmed: 24795243
Mutat Res. 2014 Jul;765:48-56
pubmed: 24769180
J Nucl Med. 2019 Aug;60(8):1073-1079
pubmed: 30683761
J Nucl Med. 2017 Oct;58(10):1624-1631
pubmed: 28408529
Ann Nucl Med. 2021 Jun;35(6):702-718
pubmed: 33871803
Biochimie. 2019 May;160:34-45
pubmed: 30742860
Int J Radiat Biol. 1993 Sep;64(3):265-73
pubmed: 8105005
Cancer. 1981 Feb 15;47(4):664-71
pubmed: 7226015
Nature. 1977 Apr 14;266(5603):653-5
pubmed: 859634
Cold Spring Harb Protoc. 2016 Aug 01;2016(8):
pubmed: 27480717
Int J Radiat Biol. 1994 Jan;65(1):7-17
pubmed: 7905912
Anticancer Res. 2001 Jan-Feb;21(1A):409-12
pubmed: 11299770
Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):153-162
pubmed: 35589012
Ann Nucl Med. 2021 Jul;35(7):753-766
pubmed: 33978932
Endocrinology. 1997 Oct;138(10):4493-6
pubmed: 9322970
Crit Rev Oncol Hematol. 2018 May;125:111-120
pubmed: 29650270
Radiother Oncol. 1988 Nov;13(3):203-9
pubmed: 3222465
Eur J Nucl Med. 2001 Apr;28(4):541-61
pubmed: 11357507
Clin Cancer Res. 2006 Feb 15;12(4):1342-8
pubmed: 16489092
Cancer Sci. 2021 Mar;112(3):1132-1140
pubmed: 33277750
J Nucl Med. 1992 Jun;33(6):1132-6
pubmed: 1597728
Radiother Oncol. 2016 Oct;121(1):154-161
pubmed: 27637859
Endocr Relat Cancer. 2021 Sep 03;28(10):T125-T140
pubmed: 34254949
J Nucl Med. 2004 Mar;45(3):500-7
pubmed: 15001694
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):721-728
pubmed: 31758224
Sci Rep. 2018 Jan 17;8(1):988
pubmed: 29343841
Curr Pharm Des. 2000 Sep;6(14):1433-55
pubmed: 10903402
J Nucl Med. 2016 Dec;57(12):1941-1944
pubmed: 27390158
J Nucl Med. 2008 Jan;49(1):30-8
pubmed: 18077533
Curr Radiopharm. 2011 Oct;4(4):321-8
pubmed: 22202154
J Nucl Med. 2019 Sep;60(9):1301-1307
pubmed: 30796173
Transl Oncol. 2020 Apr;13(4):100757
pubmed: 32220762
J Nucl Med. 2010 Feb;51(2):311-28
pubmed: 20080889
Cancer Biother Radiopharm. 2013 Nov;28(9):657-64
pubmed: 23789969

Auteurs

Tadashi Watabe (T)

Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.

Yuwei Liu (Y)

Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.

Kazuko Kaneda-Nakashima (K)

Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Core for Medicine and Science Collaborative Research and Education, Project Research Center for Fundamental Sciences, Osaka University Graduate School of Science, Suita 565-0871, Japan.

Tatsuhiko Sato (T)

Nuclear Science and Engineering Center, Japan Atomic Energy Agency, Shirakata 2-4, Tokai 319-1195, Japan.
Research Center for Nuclear Physics, Osaka University, Suita 567-0047, Japan.

Yoshifumi Shirakami (Y)

Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.

Kazuhiro Ooe (K)

Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.

Atsushi Toyoshima (A)

Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.

Eku Shimosegawa (E)

Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Department of Molecular Imaging in Medicine, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.

Yang Wang (Y)

Nishina Center for Accelerator-Based Science, RIKEN, Wako 351-0198, Japan.

Hiromitsu Haba (H)

Nishina Center for Accelerator-Based Science, RIKEN, Wako 351-0198, Japan.

Takashi Nakano (T)

Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Research Center for Nuclear Physics, Osaka University, Suita 567-0047, Japan.

Atsushi Shinohara (A)

Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Department of Chemistry, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.

Jun Hatazawa (J)

Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Research Center for Nuclear Physics, Osaka University, Suita 567-0047, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH